Stock Events
Stock Events
Features
Business
More
Login
Sign Up
Sign Up
NeuroSense Therapeutics (NRSN) Q1 2024 Earnings
NRSN
5
Apr
Confirmed
Q1 2023
Q2 2023
Q3 2023
Q1 2024
-0.28
-0.15
-0.03
0.1
Details
Expected EPS
-0.23
Actual EPS
-0.16
Surprise EPS
0.07
Surprise Percent
+30.43%
Description
NeuroSense Therapeutics (NRSN) has reported earnings of -0.16 per share for Q1 2024.
0 Comments
Share your thoughts
Get the Stock Events App
Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.
Sign Up
Login